ASX Announcements

News & Events

Year

IHL Submit IND Application for IHL42x

July 21, 2023

Fortrea to Manage IHL FDA IND Phase 2 and 3 Clinical Trial

July 18, 2023

IHL Receives HREC Approval Ph 2 Clinical Trial for IHL675

July 13, 2023

Updated IHL Intends to Redomicile to US announcement – SID

July 10, 2023

IHL Intends to Redomicile to US & List all Shares on Nasdaq

July 10, 2023

IHL Receives Ethics Approval BA – BE Clinical Trial

July 6, 2023

Change of Director’s Interest Notice

June 30, 2023

Change of Registered Office

June 26, 2023

IHL Announcement – H.C. Wainwright Virtual Conference

June 23, 2023

Principal Investigators Appointed for IHL42X Phase 2-3 Trial

June 16, 2023

Displaying 31 - 40 of 49

Investor & Media Contacts

Email Address* Required

Search Investors

Search this site